University Hospital Bispebjerg and Frederiksberg Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02698501
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Bandim Health Project and Center for Clinical Research and Prevention, Hospital of Bispebjerg and Frederiksberg | Celeste Porsbjerg | Digestive Disease Center, Bispebjerg Hospital | Digestive Disease Center, Bispebjerg Hospital, Denmark | Kristian Kiim Jensen | Professor, Department of Dermatology, Bispebjerg Hospital | Ulla Toft | Zelo Phase 1 unit, University Hospital Bispebjerg and Frederiksberg